Synthesis of coelenterazine

US11078200B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11078200-B2
Application numberUS-202016851962-A
CountryUS
Kind codeB2
Filing dateApr 17, 2020
Priority dateJun 29, 2018
Publication dateAug 3, 2021
Grant dateAug 3, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein are synthesis methods for coelenterazine. Also disclosed are articles including the coelenterazine and coelenterazine derivatives. Representative absorbent articles include disposable diapers and adult incontinence products.

First claim

Opening claim text (preview).

The embodiments of the disclosure in which an exlusive property or privelage is claimed are defined as follows: 1. A method of making coelenterazine, comprising: coupling 4-(5-amino-6-benzylpyrazin-2-yl)phenol (coelenteramine) with 3-(4-(benzyloxy)phenyl)-2-oxopropanal to provide 8-benzyl-2-(4-(benzyloxy)benzyl)-6-(4-hydroxyphenyl)imidazo[1,2-α]pyrazin-3(7H)-one; and deprotecting the 8-benzyl-2-(4-(benzyloxy)benzyl)-6-(4-hydroxyphenyl)imidazo[1,2-α]pyrazin-3(7H)-one to provide 8-benzyl-2-(4-hydroxybenzyl) -6-(4-hydroxyphenyl)imidazo [1,2-α]pyrazin-3(7H)-one (coelenterazine). 2. The method of claim 1 , wherein coupling the 4-(5-amino-6-benzylpyrazin-2-yl)phenol (coelenteramine) with the 3-(4-(benzyloxy)phenyl)-2-oxopropanal is in a solvent mixture comprising dioxane, water, and HC1. 3. The method of claim 2 , wherein coupling the 4-(5-amino-6-benzylpyrazin-2-yl)phenol (coelenteramine) with the 3-(4-(benzyloxy)phenyl)-2-oxopropanal is at a temperature of 75° C. to 90° C. for 12 to 36 hours in an inert atmosphere. 4. The method of claim 1 , wherein deprotecting the 8-benzyl-2-(4-(benzyloxy)benzyl)-6-(4-hydroxyphenyl)imidazo[1,2-α]pyrazin-3(7H)-one comprises a first deprotection step of exposing the 8-benzyl-2-(4-(benzyloxy)benzyl)-6-(4-hydroxyphenyl)imidazo[1,2-α]pyrazin-3(7H)-one to HC1 in an organic solvent comprising dioxane, and isolating and drying an intermediate deprotected product. 5. The method of claim 4 , wherein the first deprotection step is at a temperature of 25° C. to 40 ° C. 6. The method of claim 4 , further comprises a second deprotection step of exposing the dried intermediate deprotected product to HC1 in an organic solvent comprising dioxane. 7. The method of claim 6 , wherein the second deprotection step comprises heating the intermediate deprotected product in HC1 and the organic solvent to a temperature of about 70° C. to 75° C. for a duration of 12 to 24 hours to provide coelenterazine. 8. The method of claim 1 , wherein the coelenterazine is obtained in a yield of greater than 70% at a purity of from 55% to 70% relative to 4-(5-amino-6-benzylpyrazin-2-yl)phenol. 9. The method of claim 1 , further comprising making the 3-(4-(benzyloxy)phenyl)-2-oxopropanal by reacting 1-(benzyloxy)-4-(chloromethyl)benzene in two steps to provide 3-(4-(benzyloxy)phenyl)-2-oxopropanal. 10. The method of claim 9 , wherein making the 3-(4-(benzyloxy)phenyl)-2-oxopropanal does not include more than one palladium-catalyzed reaction. 11. The method of claim 9 , comprising a first step of reacting the 1-(benzyloxy)-4-(chloromethyl)benzene with methyl 2,2-dimethoxyacetate, ethyl bromide, magnesium, and a catalytic amount of iodine to provide 3-(4-(benzyloxy)phenyl)-1,1-dimethoxypropan-2-one. 12. The method of claim 11 , wherein the 3-(4-(benzyloxy)phenyl)-1,1-dimethoxypropan-2-one is purified by silica column chromatography. 13. The method of claim 12 , further comprising a second step of reacting the 3-(4-(benzyloxy)phenyl)-1,1-dimethoxypropan-2-one with aqueous HC1 to provide the 3-(4-(benzyloxy)phenyl)-2-oxopropanal. 14. The method of claim 9 , wherein the 3-(4-(benzyloxy)phenyl)-2-oxopropanal is isolated in a yield of 60 to 75% at a purity of 85 to 95% relative to 1-(benzyloxy)-4-(chloromethyl)benzene.

Assignees

Inventors

Classifications

  • Ketones; Ketenes; Dimeric ketenes (heterocyclic compounds C07D, e.g. beta-lactones C07D305/12); Ketonic chelates · CPC title

  • C07D487/04Primary

    Ortho-condensed systems · CPC title

  • with carboxylic acids or their derivatives · CPC title

  • C07D471/04Primary

    Ortho-condensed systems · CPC title

  • the singly bound functional group being an acetalised, ketalised hemi-acetalised, or hemi-ketalised hydroxyl group (cyclic acetals or ketals C07C45/59, C07C45/60) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11078200B2 cover?
Disclosed herein are synthesis methods for coelenterazine. Also disclosed are articles including the coelenterazine and coelenterazine derivatives. Representative absorbent articles include disposable diapers and adult incontinence products.
Who is the assignee on this patent?
Int Paper Co
What technology area does this patent fall under?
Primary CPC classification C07D487/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).